COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients.

Emil SundbergTove HoffmanAnna NilssonSimon PahnkeGunilla EnbladLinda KolstadBengt RönnbergÅke LundkvistMilla TorkkiOtto ZhouJenna AndersonArja H Harila-SaariJosefine Palle

Published in: Pediatric blood & cancer (2022)

Swedish pediatric oncology and hematology patients developed antibodies against SARS-CoV-2, despite their diagnosis and/or treatment, and the observed seroprevalence was similar to that in national pediatric outpatients. PCR-verified cases underestimate the true incidence of COVID-19 in this patient cohort.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
palliative care
peritoneal dialysis
patient reported outcomes
case report
young adults
childhood cancer